Could skipping routine heparin be safer for heart patients?
NCT ID NCT06981624
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving the blood thinner heparin only when needed, instead of routinely, can prevent radial artery occlusion after a heart catheterization procedure. Researchers will enroll 500 patients and compare rates of artery patency, bleeding, and nursing time. The goal is to see if a selective approach works just as well with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
heparin
What this could lead to
If successful, this could show that giving heparin only when needed is just as effective as routine use, potentially reducing unnecessary medication and nursing workload.
What could go wrong
This is a moderate-sized trial (500 participants) comparing two strategies, not a new drug. The results may not change standard practice if selective heparin leads to more occlusions or complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIAL ARTERY OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUCPQ
RECRUITINGQuébec, Quebec, G1V4G5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••